Galderma to Acquire ZO Skin Health for $1.5 Billion
Galderma, maker of Cetaphil, will acquire physician-dispensed skincare brand ZO Skin Health for $1.5 billion, deepening its push into medical-grade skincare.
Topic
Topic
Galderma, maker of Cetaphil, will acquire physician-dispensed skincare brand ZO Skin Health for $1.5 billion, deepening its push into medical-grade skincare.